Institutes outside Greece
Evaluation of multipotent adult progenitor cells as a candidate therapy for multiple sclerosis
Abstract
dc:descriptionMultiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by neuroinflammation, demyelination, and progressive neurological decline. Current therapies mainly target immune modulation but fail to provide neuroprotection or promote repair. In this thesis, the therapeutic potential of multipotent adult progenitor cells (MAPC), a stem cell population with superior expansion capacity compared to mesenchymal stem cells, was evaluated in the context of MS. Using in vitro models, rat-derived MAPC (rMAPC) were shown to suppress autoreactive T-cell proliferation, inhibit macrophage activation, and secrete immunomodulatory mediators such as nitric oxide and prostaglandin E2. These effects were further enhanced when MAPC were exposed to pro-inflammatory cytokines, demonstrating that neuroinflammatory signals can boost their immunomodulatory and neuroprotective functions. MAPC also displayed chemokine-driven migratory properties, enabling them to home to inflamed sites, and promoted the survival of oligodendrocytes under oxidative stress. In vivo experiments in experimental autoimmune encephalomyelitis (EAE) revealed that human MAPC (hMAPC), but not rMAPC, ameliorated disease symptoms, particularly in relapsing-remitting models. The beneficial effects were associated with reduced peripheral T-cell activation and downregulation of pro-inflammatory mediators in the central nervous system. Importantly, MAPC did not exacerbate disease, even under inflammatory conditions, supporting their low immunogenic profile. Collectively, these findings identify MAPC as promising candidates for cell-based therapy in MS, highlighting their capacity to adapt to the host microenvironment and exert both immunomodulatory and neuroprotective effects. This work further underscores the potential of MAPC for translation into future clinical applications in neuroinflammatory diseases.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ravanidis, Stylianos
- Ραβανίδης, Στυλιανός
Subjects
dc:subject × 26- Πολλαπλή σκλήρυνση
- Αναγεννητική ιατρική
- Νευροανοσολογία
- Κυτταρική θεραπεία
- Κύτταρα, Μεσεγχυματικά πολυδύναμα
- Κυτταρική μεταμόσχευση
- Αυτοφλεγμονή
- Multiple sclerosis
- Regenerative medicine
- Neuroimmunology
- Cellular therapy
- Cells, Mesenchymal stem
- Cell transplantation
- Autoinflammation
- Βιολογία
- Φυσικές Επιστήμες
- Βιοχημεία και Μοριακή βιολογία
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Νευροεπιστήμες
- Biological Sciences
- Natural Sciences
- Biochemistry and Molecular Biology
- Basic Medicine
- Medical and Health Sciences
- Neurosciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59819